Daxor corporation announces pricing of $2.0 million underwritten public offering

Oak ridge, tn, nov. 15, 2022 (globe newswire) -- daxor corporation (nasdaq: dxr) (“daxor”, or the “company”), the global leader in blood volume measurement technology, today announced the pricing of an underwritten public offering consisting of 210,527 shares of its common stock at a public offering price of $9.50 per share. the gross proceeds to daxor from the offering, before deducting the underwriting commissions and other estimated offering expenses payable by daxor, are expected to be $2.0 million. in addition, daxor has granted the underwriter in the offering a 45-day option to purchase up to an additional 10,527 shares of its common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments in connection with the offering. the offering is expected to close on november 17, 2022, subject to customary closing conditions.
DXR Ratings Summary
DXR Quant Ranking